DUBLIN--(BUSINESS WIRE)--The "Bovine Respiratory Disease Treatment: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global bovine respiratory disease treatment to grow with a CAGR of 6.6% over the forecast period of 2018-2024.
The report on bovine respiratory disease treatment is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global bovine respiratory disease treatment over the period of 2016 to 2024.
The factors responsible for driving the growth of bovine respiratory disease treatment includes development of novel products and increase in preventive measures against bovine respiratory disease. Furthermore, increase in cattle population across the globe to meet the growing demand of meat consumption. This increase in cattle population is likely to increase chances of bovine respiratory disease among cattle that may facilitate growth in bovine respiratory disease treatment market.
However, less awareness about the bovine respiratory disease and its treatment, particularly in developing and underdeveloped regions are some of the restraints that is likely to hinder the growth in the bovine respiratory disease treatment market. Furthermore, advancement of vaccines to treat BRD is likely to boost the bovine respiratory disease market.
Key Topics Covered
2. Executive Summary
3. Global Bovine Respiratory Disease Treatment Overview
4. Global Bovine Respiratory Disease Treatment by Disease Type
5. Global Bovine Respiratory Disease Treatment by Treatment Type
6. Global Bovine Respiratory Disease Treatment by Distribution Channel
7. Global Bovine Respiratory Disease Treatment by Region 2018-2024
8. Companies Covered
- Bayer AG
- Boehringer Ingelheim GmbH
- Bimeda Animal Health
- Zoetis Services LLC
- Virbac Group
For more information about this report visit https://www.researchandmarkets.com/research/x9b68w/global_bovine?w=4